3 Results for "

RIP1/RIP3/MLKL pathway

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "RIP1/RIP3/MLKL pathway" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-144828
CAS No.: 2682850-41-3
Purity:  ≥97.0%
Research Areas:  

Cancer

RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability .
loading...
    loading...
Cat. No.: HY-173185
Target:  

RIP kinase Necroptosis

Research Areas:  

Inflammation/Immunology

RIP1-IN-1 is an orally active RIP1 inhibitor with strong RIP1 binding affinity (Kd: 110 nM). RIP1-IN-1 exhibits strong anti-necroptosis activity. RIP1-IN-1 effectively inhibits the formation of necrosomes by blocking the phosphorylation of RIP1, RIP3 and MLKL signaling pathways. RIP1-IN-1 inhibits necroptosis and can be used in the study of acute liver injury .
loading...
    loading...
Cat. No.: HY-148767
CAS No.: 2755872-58-1
Research Areas:  

Others

MLKL-IN-5 is a mixed lineage kinase domain-like protein (MLKL) inhibitor with a KD of < 10 nM. MLKL-IN-5 exhibits selectivity for RIP3 and RIP1, with KD values of 1-30 μM and > 30 μM, respectively. MLKL-IN-5 mediates necroptosis .
loading...
    loading...